[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (1,150)

Search Parameters:
Keywords = preterm neonate

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
15 pages, 934 KiB  
Article
Factors Associated with the Prolonged Use of Donor Human Milk at the Da Nang Hospital for Women and Children in Vietnam
by Hoang Thi Tran, Tuan Thanh Nguyen, Oanh Thi Xuan Nguyen, Le Thi Huynh and Roger Mathisen
Nutrients 2024, 16(24), 4402; https://doi.org/10.3390/nu16244402 - 22 Dec 2024
Viewed by 343
Abstract
Background and Objectives: Donor human milk (DHM) from a human milk bank (HMB) is used to feed low-birthweight (LBW) and preterm infants when mothers cannot provide their own breastmilk. The misuse of DHM could interfere with mothers’ breastmilk and weaken breastfeeding efforts. This [...] Read more.
Background and Objectives: Donor human milk (DHM) from a human milk bank (HMB) is used to feed low-birthweight (LBW) and preterm infants when mothers cannot provide their own breastmilk. The misuse of DHM could interfere with mothers’ breastmilk and weaken breastfeeding efforts. This study aimed to identify factors behind prolonged DHM usage during the first six years of Vietnam’s first HMB. Methods: Data were extracted from the Da Nang HMB’s digital monitoring system. We defined prolonged DHM use as four or more days in the neonatal unit and two or more days in postnatal wards. Results: Over six years, 25,420 infants received DHM, with 45.3% of the infants being female, 54.7% being male, 70.0% being born via cesarean section, and 77.2% being full-term. In the neonatal unit (n = 7001), 38.0% of infants used DHM for ≥4 days. Adjusted odds ratios (aORs) for prolonged use were 0.14 for infants weighing <1000 g, 0.78 for infants weighing 1000–<1500 g, and 0.67 for infants weighing ≥2000 g (p < 0.01), compared to those weighing 1500–<2000 g. Compared to gestational ages of 32–<34 weeks, the aORs were 0.26 for <28 weeks, 0.71 for 34–<37 weeks, and 0.35 for ≥37 weeks (p < 0.01). In postnatal wards (n = 18,419), 53.1% of infants used DHM for ≥2 days. Compared to term, normal-weight infants, the aORs were 1.25 for LBW–preterm, 1.17 for LBW–term, and 1.21 for normal-weight–preterm infants (p < 0.05). Prolonged DHM use was associated with cesarean births in neonatal units (aOR 2.24, p < 0.01) and postnatal wards (aOR 1.44, p < 0.01). Conclusions: DHM is used briefly to bridge nutritional gaps and transition to mothers’ breastmilk, but LBW, preterm births, and cesarean births are linked to prolonged use. Healthcare providers should support those at risk of prolonged DHM use and prioritize reducing unnecessary cesarean births. Full article
(This article belongs to the Special Issue Own or Donated Human Milk: Its Role in Today's Society)
Show Figures

Figure 1

Figure 1
<p>Distribution (%) of duration of use of DHM (days) in neonatal units (<b>A</b>) and postnatal wards (<b>B</b>) by year.</p>
Full article ">Figure 2
<p>Adjusted ORs of prolonged DHM use in neonatal unit for birth weight categories (<b>A</b>) and gestation age (<b>B</b>) and postnatal wards for birth weight and gestational age categories (<b>C</b>). All models controlled for child sex, mothers from other provinces, cesarean births, and births before 2020; the model in panel A controlled for gestational age in a continuous form; and the model in panel A controlled for birth weight in a continuous form.</p>
Full article ">
11 pages, 468 KiB  
Article
Longer Duration of Cord Clamping Improves Nicu Survival Without Major Morbidities in Very Preterm Infants
by Priya Jegatheesan, Esther Belogolovsky, Matthew Nudelman, Sudha Rani Narasimhan, Angela Huang, Balaji Govindaswami and Dongli Song
Children 2024, 11(12), 1546; https://doi.org/10.3390/children11121546 - 20 Dec 2024
Viewed by 326
Abstract
Background: Longer duration of deferred cord clamping (DCC), at least 120 s, is associated with the highest reduction in mortality compared to shorter durations of DCC or immediate cord clamping in preterm infants. We compared the neonatal outcomes of very preterm infants who [...] Read more.
Background: Longer duration of deferred cord clamping (DCC), at least 120 s, is associated with the highest reduction in mortality compared to shorter durations of DCC or immediate cord clamping in preterm infants. We compared the neonatal outcomes of very preterm infants who received at least 60 s to those who received at least 120 s of DCC. Methods: This is a retrospective single-center study including preterm infants born <33 weeks of gestational age (GA) between 2014 and 2019. The intended duration of DCC was 60 s in Period 1 (January 2014 to June 2016, n = 139) and 120 to 180 s in Period 2 (July 2016 to December 2019, n = 155). We compared the demographics, delivery room measures, and neonatal outcomes between the two periods as intent-to-treat analysis and per protocol analysis. Results: The intended duration of DCC was completed in 75% of infants in Period 1 (n = 106) and 76% of infants in Period 2 (n = 114). There was an increase in survival without major morbidities in the infants that received at least 120 s of DCC, which remained significant after adjusting for GA and erythropoietin use (Odds ratio 8.6, 95% CI 1.6 to 45.7). Conclusions: Longer duration of DCC is associated with improved survival without major morbidities in preterm infants <33 weeks GA. Full article
(This article belongs to the Special Issue Care and Outcome of the Extreme Preterm Infant)
Show Figures

Figure 1

Figure 1
<p>Enrollment.</p>
Full article ">
28 pages, 3756 KiB  
Review
Unveiling the Emerging Role of Extracellular Vesicle–Inflammasomes in Hyperoxia-Induced Neonatal Lung and Brain Injury
by Karen Young, Merline Benny, Augusto Schmidt and Shu Wu
Cells 2024, 13(24), 2094; https://doi.org/10.3390/cells13242094 - 18 Dec 2024
Viewed by 513
Abstract
Extremely premature infants are at significant risk for developing bronchopulmonary dysplasia (BPD) and neurodevelopmental impairment (NDI). Although BPD is a predictor of poor neurodevelopmental outcomes, it is currently unknown how BPD contributes to brain injury and long-term NDI in pre-term infants. Extracellular vesicles [...] Read more.
Extremely premature infants are at significant risk for developing bronchopulmonary dysplasia (BPD) and neurodevelopmental impairment (NDI). Although BPD is a predictor of poor neurodevelopmental outcomes, it is currently unknown how BPD contributes to brain injury and long-term NDI in pre-term infants. Extracellular vesicles (EVs) are small, membrane-bound structures released from cells into the surrounding environment. EVs are involved in inter-organ communication in diverse pathological processes. Inflammasomes are large, multiprotein complexes that are part of the innate immune system and are responsible for triggering inflammatory responses and cell death. Apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) is pivotal in inflammasome assembly and activating inflammatory caspase-1. Activated caspase-1 cleaves gasdermin D (GSDMD) to release a 30 kD N-terminal domain that can form membrane pores, leading to lytic cell death, also known as pyroptosis. Activated caspase-1 can also cleave pro-IL-1β and pro-IL-18 to their active forms, which can be rapidly released through the GSDMD pores to induce inflammation. Recent evidence has emerged that activation of inflammasomes is associated with neonatal lung and brain injury, and inhibition of inflammasomes reduces hyperoxia-induced neonatal lung and brain injury. Additionally, multiple studies have demonstrated that hyperoxia stimulates the release of lung-derived EVs that contain inflammasome cargos. Adoptive transfer of these EVs into the circulation of normal neonatal mice and rats induces brain inflammatory injury. This review focuses on EV–inflammasomes’ roles in mediating lung-to-brain crosstalk via EV-dependent and EV-independent mechanisms critical in BPD, brain injury, and NDI pathogenesis. EV–inflammasomes will be discussed as potential therapeutic targets for neonatal lung and brain injury. Full article
(This article belongs to the Special Issue Perinatal Brain Injury—from Pathophysiology to Therapy)
Show Figures

Figure 1

Figure 1
<p>Mouse model of hyperoxia-induced BPD. Newborn mice were exposed to room air (RA) or 85% O<sub>2</sub> from P1 to P14. (<b>A</b>,<b>B</b>): Lung morphology was assessed by mean linear intercept (MLI) (<b>C</b>) and radial alveolar count (RAC) (<b>D</b>). Hyperoxia exposure increased MLI and decreased RAC, suggesting impaired alveolarization. (<b>E</b>,<b>F</b>): immunostaining for vWF (white arrows) and alpha-smooth muscle actin (α-SMA) (red arrows). Hyperoxia exposure reduced vWF+ vessel counts (<b>G</b>) and increased α-SMA positive vessels (<b>H</b>). Magnification: 20×. Scale bar: 50 μm. *** <span class="html-italic">p</span> &lt; 0.001. **** <span class="html-italic">p</span> &lt; 0.0001. Ref. [<a href="#B55-cells-13-02094" class="html-bibr">55</a>] with permission.</p>
Full article ">Figure 2
<p>Hyperoxia-induced neonatal brain injury in mice. Hyperoxia increases neuroinflammation and oxidative stress and decreases neurotrophins. These lead to brain cell death and impaired differentiation, altered brain microvascular development, and impaired myelination and axonal development. NGF: nerve growth factor. BDNF: brain-derived neurotrophic factor. VEGF: vascular endothelial growth factor. NT-3: neurotrophin-3. NT-4: neurotrophin-4. Ref. [<a href="#B68-cells-13-02094" class="html-bibr">68</a>] with permission.</p>
Full article ">Figure 3
<p>Structure, cargo, and function of extracellular vesicles. Extracellular vesicles (EVs) are composed of a lipid bilayer containing transmembrane proteins with a cargo consisting of proteins, mRNA, miRNA, DNA, and lipids. EVs can be isolated from various body fluids and have a diverse range of sizes ranging from 100 to 1000 nm. EVs isolated from the lung fluids and peripheral blood can be used as biomarkers for neonatal lung diseases. EVs have also been linked to the mediation of neonatal lung disease-associated brain injury.</p>
Full article ">Figure 4
<p>Characterization of EVs. (<b>A</b>,<b>B</b>): Nanoparticle tracking demonstrates that sizes and concentrations of EVs isolated from the plasma of pre-term infants on lower O<sub>2</sub> (LO<sub>2</sub>, &lt;30%) and higher O<sub>2</sub> (HO<sub>2</sub>, &gt;30%) on the seventh day of life. (<b>C</b>–<b>E</b>): transmission electron microscopy (TEM) shows the EV particles are smaller in size in the HO<sub>2</sub> group (red arrows). (<b>F</b>–<b>H</b>): Western blot analysis detects EV surface markers, CD9, CD63, and CD81. The CD63 and CD81 expression levels of the HO<sub>2</sub> group are lower than the LO<sub>2</sub> group. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01. Scale bar: 200 nm. Ref. [<a href="#B106-cells-13-02094" class="html-bibr">106</a>] with permission.</p>
Full article ">Figure 5
<p>Activation of NLRP3 inflammasome. NLRP3 inflammasome activation requires 2 steps: priming and activation. During the priming step, expression of NLRP3 and other inflammasome components is increased by activation of NF-κB upon PAMPs or DAMPs interaction with toll-like receptors (TLR). In the activation step, NLRP3 is activated by diverse stimuli and the formation of NLRP3 inflammasome that relies on homotypic interaction between the pyrin domain (PYD) and caspase-recruitment domain (CARD). ASC is recruited to cluster PRDs of oligomerized NLRP3 molecules, creating a platform for recruiting the effector caspase-1. The CARD of the procaspase-1 can interact with the aggregated CARDs of ASC, resulting in autolytic cleavage of pro-caspase-1 to P20 and P10 subunits that lead to caspase-1 activation. The activated caspase-1 can cleave and activate GSDMD to release an N-terminal domain that forms membrane pores and leads to pyroptosis. The caspase-1 can also cleave pro-IL-1β and pro-IL-18 to their active forms, IL-1β and IL-18, which can be rapidly released via the GSDMD pores into the extracellular space, leading to inflammation.</p>
Full article ">Figure 6
<p>GSDMD-KO reduces hyperoxia modulation of inflammatory, tissue remodeling, and developmental pathways in the neonatal lung. (<b>A</b>). Over-representation analysis using Toppcluster to identify similarities and dissimilarities of Gene Ontology terms and pathways modulated by hyperoxia in WT and GSDMD-KO lungs. Bars represent the log p-value, and the number of genes associated with each term is displayed at the end of the bar. In GSDMD-KO lungs, genes induced by hyperoxia were more strongly associated with TNF superfamily cytokine production, cellular extravasation, and cellular response to IFN-g, while suppressed genes in GSDMD-KO were uniquely associated with lobar bronchus epithelium development and B cell receptor signaling pathways. n = 3 animals/group. qRT-PCR validation of differentially expressed genes between hyperoxia-exposed WT and hyperoxia-exposed GSDMD-KO lungs included <span class="html-italic">Alas2</span> (<b>B</b>), <span class="html-italic">Scl4a1</span> (<b>C</b>), <span class="html-italic">Edn1</span> (<b>D</b>), <span class="html-italic">Mif</span> (<b>E</b>), <span class="html-italic">Pik3cg</span> (<b>F</b>), and <span class="html-italic">Trem2</span> (<b>G</b>). n = 4/group. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, WT-O<sub>2</sub> vs. WT-RA. <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01, WT-O<sub>2</sub> vs. KO-O<sub>2</sub>. Ref. [<a href="#B55-cells-13-02094" class="html-bibr">55</a>] with permission.</p>
Full article ">Figure 7
<p>Adoptively transferred circulating EVs track to the lung and brain of normal neonatal rats. EVs isolated from the plasma of room air-maintained (RA) or hyperoxia-exposed (O<sub>2</sub>) rats were labeled with Exo-Glow and adoptively transferred into normal neonatal rats by intravenous injection. As illustrated in (<b>A</b>–<b>C</b>), both Exo-Glow labeled RA-EVs and O<sub>2</sub>-EVs rapidly distributed throughout the body and were localized in both lung and brain at 1 and 4 h after tail vein injection. Their homing to the brain (<b>D</b>) and lung (<b>E</b>) tissues was further confirmed by ex vivo imaging after dissection at 4 h. To determine if circulating EVs can cross BBB and are present in brain tissue for longer than 4 h, Dil-dye labeled EVs were similarly injected via tail veins, and at 24 h, EVs were isolated from the CSF and examined in brain tissues. The Dil signals were detected in the brain tissue sections of rats injected with both RA-EVs and O<sub>2</sub>-EVs but not from sham animals (<b>F</b>–<b>H</b>). Magnification: 20×. Scale bars: 50 μm. In addition, high concentrations of CSF EV particles were detected in animals that received either RA-EVs ((<b>J</b>), 17.55 ± 1.9 × 10<sup>7</sup>, n = 2 pooled of 3 CSF, <span class="html-italic">p</span> &lt; 0.01) or O<sub>2</sub>-EVs ((<b>K</b>), 26.7 ± 16.6 × 10<sup>7</sup>, n = 2 pooled of 3 CSF, <span class="html-italic">p</span> &lt; 0.05), compared to the sham animals ((<b>I</b>), 4.95 ± 0.57 × 10<sup>7</sup>, n = 4 pooled of 3 CSF). Overall, these results confirm that hyperoxia-induced circulating EVs can cross BBB and be taken up by brain cells. Ref. [<a href="#B56-cells-13-02094" class="html-bibr">56</a>] with permission.</p>
Full article ">Figure 8
<p>EV-inflammasome mediated lung-brain axis. The alveolar macrophages (AMs) in early injured lungs release EVs that contain an increased cargo of ASC. These EVs contribute to BPD pathogenesis by inducing lung inflammation and inhibiting alveolarization and vascularization. These EVs are released to the circulation, cross the BBB, and are taken up by neural cells. The ASC cargo can activate GSDMD in specific neural cells and result in brain injury by activating microglial cells and inducing cell death, possibly through pyroptosis mechanisms. The molecular and cellular changes can lead to long-term neurodevelopmental impairment (NDI). Ref. [<a href="#B106-cells-13-02094" class="html-bibr">106</a>] with permission.</p>
Full article ">
11 pages, 1672 KiB  
Article
Bioelectrical Impedance Vector Analysis in Extremely Low-Birth-Weight Infants to Assess Nutritional Status: Breakthroughs and Insights
by Raquel Núñez-Ramos, Diana Escuder-Vieco, Carolina Rico Cruz, Cristina De Diego-Poncela, Sara Vázquez-Román, Marta Germán-Díaz, Nadia Raquel García-Lara and Carmen Pallás-Alonso
Nutrients 2024, 16(24), 4348; https://doi.org/10.3390/nu16244348 - 17 Dec 2024
Viewed by 338
Abstract
Background/Objectives: To obtain bioelectrical data to assess nutritional status for extremely low-birth-weight (ELBW) infants upon reaching term-corrected age. Methods: A descriptive, observational, prospective, and single-center study, which included ELBW preterm infants was performed. The study variables collected were gestational age, sex, [...] Read more.
Background/Objectives: To obtain bioelectrical data to assess nutritional status for extremely low-birth-weight (ELBW) infants upon reaching term-corrected age. Methods: A descriptive, observational, prospective, and single-center study, which included ELBW preterm infants was performed. The study variables collected were gestational age, sex, and anthropometry at birth and at term-corrected age. Bioelectrical impedance vector analysis (BIVA) was performed by a phase-sensitive device (BIA 101 BIVA PRO AKERN srl, Pisa, Italy). The components of the impedance vector—resistance (R) and reactance (Xc)—were normalized for body height (H). For each subject, the measurement was taken between the 36th and 44th weeks of postmenstrual age (PMA). A semi-quantitative analysis of body composition was performed using the vector modality of the BIA. Using the RXc graph method, the bivariate 95% confidence intervals of the mean vectors were constructed. From the bivariate normal distribution of R/H and Xc/H, the bivariate 95%, 75%, and 50% tolerance intervals for this cohort were drawn. The individual impedance vectors were compared with the distribution of the vectors from other populations. Results: 85 ELBW infants (40 male, 45 female) were included, with a mean gestational age at birth of 26 + 6 weeks (±1.76). Mean R/H was 870.33 (±143.21) Ohm/m and Xc/H was 86.84 (±19.05) Ohm/m. We found differences in the bioelectrical data with regard to gender, with resistance values being significantly higher in females. Our ellipses align closely with those from other term neonatal cohorts. Conclusions: Bioelectrical data and the confidence and tolerance ellipses of an ELBW infant cohort are presented and can be used as a reference standard for nutritional assessment at discharge. Full article
Show Figures

Figure 1

Figure 1
<p>Placement of the electrodes on the patient.</p>
Full article ">Figure 2
<p>Mean impedance vector with the 95% confidence ellipse for ELBW infants at term-corrected age. (<b>a</b>) Total cohort. (<b>b</b>) By gender.</p>
Full article ">Figure 3
<p>Tolerance ellipses for extremely premature infants at term-corrected age.</p>
Full article ">Figure 4
<p>Mean impedance vector with the 95% confidence ellipse for ELBW infants at term-corrected age. (<b>a</b>) According to SGA and (<b>b</b>) according to EUGR.</p>
Full article ">Figure 5
<p>Mean impedance vector with the 95% confidence ellipse for our cohort and Redondo del Río et al.’s [<a href="#B20-nutrients-16-04348" class="html-bibr">20</a>] and Piccoli et al.’s [<a href="#B16-nutrients-16-04348" class="html-bibr">16</a>] populations.</p>
Full article ">Figure 6
<p>Individual impedance vectors in Redondo et al.’s [<a href="#B20-nutrients-16-04348" class="html-bibr">20</a>] ellipses.</p>
Full article ">
16 pages, 631 KiB  
Article
Assessing the Impact of COVID-19 on Pregnancy and Maternal Outcomes: A Slovak National Study
by Adriána Goldbergerová, Ladislav Kováč, Cecília Marčišová, Miroslav Borovský, Dominika Kotríková, Ľubomíra Izáková, Ján Mikas, Jana Námešná, Zuzana Krištúfková and Alexandra Krištúfková
Reprod. Med. 2024, 5(4), 319-334; https://doi.org/10.3390/reprodmed5040028 - 16 Dec 2024
Viewed by 465
Abstract
Background: The COVID-19 pandemic highlighted the global challenge of inadequate data on SARS-CoV-2’s effects on pregnant women and their infants. In response, Slovakia, along with other countries, launched a nationwide study to assess the incidence, characteristics, and outcomes of SARS-CoV-2 infection during [...] Read more.
Background: The COVID-19 pandemic highlighted the global challenge of inadequate data on SARS-CoV-2’s effects on pregnant women and their infants. In response, Slovakia, along with other countries, launched a nationwide study to assess the incidence, characteristics, and outcomes of SARS-CoV-2 infection during pregnancy. Methods: We conducted a national observational descriptive study of SARS-CoV-2 positive cases among pregnant women from the pandemic’s onset to its conclusion. In collaboration with the Public Health Office of the Slovak Republic, we identified 1184 pregnant women who tested positive for SARS-CoV-2 and contacted them for participation. Results: Among the 240 participating SARS-CoV-2-positive pregnant women, 13 required hospitalizations, with an increased need for intensive care and respiratory support. However, the absolute risk of poor outcomes remained low. Higher maternal age and infection during the third trimester emerged as key risk factors for hospitalization. A symptomatic course was dominant, with fatigue (70%), headache (58%), and fever (56%) as the leading symptoms. While maternal and neonatal outcomes were generally favourable, a slight increase in caesarean sections and preterm births suggests an indirect impact on maternity care. Vaccination during pregnancy correlated with reduced symptoms and no hospitalizations. Elevated CRP levels were common among infected women, while ultrasound findings remained normal. Conclusions: This study offers a multi-dimensional view of pregnancy during the pandemic, capturing both the mother’s personal concerns and the objective insights from prenatal and labour care settings. The findings suggest that most pregnant women with SARS-CoV-2 experience mild to moderate illness, offering reassurance to clinicians about generally favourable maternal and neonatal outcomes while underscoring the need for vigilance in rare severe cases. Full article
Show Figures

Figure 1

Figure 1
<p>Study flowchart—data collection from 1 March 2020 and 5 May 2023.</p>
Full article ">
29 pages, 2179 KiB  
Review
Bovine Colostrum in Pediatric Nutrition and Health
by Ahmet Alperen Canbolat, Mauro Lombardo, Alicia del Carmen Mondragon, Jose Manuel Miranda López, Mikhael Bechelany and Sercan Karav
Nutrients 2024, 16(24), 4305; https://doi.org/10.3390/nu16244305 - 13 Dec 2024
Viewed by 736
Abstract
Bovine colostrum (BC), the first milk secreted by mammals after birth, is a trending alternative source for supplementing infants and children, offering benefits for gut and immune health. Its rich components, such as proteins, immunoglobulins, lactoferrin, and glycans, are used to fortify diets [...] Read more.
Bovine colostrum (BC), the first milk secreted by mammals after birth, is a trending alternative source for supplementing infants and children, offering benefits for gut and immune health. Its rich components, such as proteins, immunoglobulins, lactoferrin, and glycans, are used to fortify diets and support development. Preterm development is crucial, especially in the maturation of essential systems, and from 2010 to 2020, approximately 15% of all premature births occurred at less than 32 weeks of gestation worldwide. This review explores the composition, benefits, and effects of BC on general infants and children, along with preterm infants who require special care, and highlights its role in growth and development. BC is also associated with specific pediatric diseases, including necrotizing enterocolitis (NEC), infectious diarrhea, inflammatory bowel disease (IBD), short-bowel syndrome (SBS), neonatal sepsis, gastrointestinal and respiratory infections, and some minor conditions. This review also discusses the clinical trials regarding these specific conditions which are occasionally encountered in preterm infants. The anti-inflammatory, antimicrobial, immunomodulatory, and antiviral properties of BC are discussed, emphasizing its mechanisms of action. Clinical trials, particularly in humans, provide evidence supporting the inclusion of BC in formulas and diets, although precise standards for age, feeding time, and amounts are needed to ensure safety and efficacy. However, potential adverse effects, such as allergic reactions to caseins and immunoglobulin E, must be considered. More comprehensive clinical trials are necessary to expand the evidence on BC in infant feeding, and glycans, important components of BC, should be further studied for their synergistic effects on pediatric diseases. Ultimately, BC shows promise for pediatric health and should be incorporated into nutritional supplements with caution. Full article
(This article belongs to the Special Issue Advances in Infant and Pediatric Feeding and Nutrition)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>The key components of bovine colostrum. The antimicrobial and immune-modulating properties, growth factors, and nutrients of BC are essential for infants. The relative concentrations of BC differ daily and transform into milk 7 days after parturition (created with <a href="http://BioRender.com" target="_blank">BioRender.com</a>, accessed on 27 August 2024).</p>
Full article ">Figure 2
<p>This chart shows the mean (±) levels of total solid components present in BC and mature milk [<a href="#B2-nutrients-16-04305" class="html-bibr">2</a>]. The difference between BC and mature milk indicates that while BC supports immunity and growth in newborn infants, mature milk is prevalent in terms of its nutritional ingredients. (Created with <a href="http://meta-chart.com" target="_blank">meta-chart.com</a>, accessed on 24 August 2024).</p>
Full article ">Figure 3
<p>The hindering mechanism between <span class="html-italic">Enterobacteriaceae</span> and specific colostrum components. The figure illustrates the regulation of <span class="html-italic">Enterobacteriaceae</span> species in the infant gut, including pathogenic bacteria such as <span class="html-italic">E. coli</span> and <span class="html-italic">Salmonella</span>. Its bioactive components, particularly immunoglobulin A (IgA) and lactoferrin (LF), have strong antimicrobial properties. IgA binds to pathogenic bacteria, neutralizing them and preventing their attachment to the gut lining, whereas LF inhibits bacterial growth by sequestering iron, a nutrient essential for these bacteria. (Created with <a href="http://BioRender.com" target="_blank">BioRender.com</a>, access date: 7 September 2024).</p>
Full article ">Figure 4
<p>The interaction between milk oligosaccharides and Bifidobacteria species. Human milk oligosaccharides (HMOs), such as those found in human or bovine milk and colostrum, play a critical role in promoting the growth of <span class="html-italic">Bifidobacterium</span> in the infant gut, acting as selective prebiotics. <span class="html-italic">Bifidobacterium</span> ferments these oligosaccharides, producing short-chain fatty acids (SCFAs) such as acetate and butyrate, which help maintain gut health by lowering the pH and inhibiting pathogenic bacteria. This interaction also enhances the gut barrier, preventing harmful microbes from entering the bloodstream and supporting immune system development.</p>
Full article ">Figure 5
<p>The biological effects of BC and its mechanisms of action. BC supports a healthy epithelium and administers immunoglobulins and growth factors to support immunity and induce cell proliferation. Milk oligosaccharides strengthen the gut barrier by promoting the development of the gut lining. The colostrum also contains immunoglobulins that help prime dendritic cells (DCs). Antibodies can bind to pathogens, making them easier for DCs to recognize, process, and present as antigens to T cells. This mechanism enhances the ability of the immune system to establish an effective response to infections in newborn infants. (Created with <a href="http://BioRender.com" target="_blank">BioRender.com</a>, accessed on 7 September 2024).</p>
Full article ">
13 pages, 266 KiB  
Review
Lung Ultrasound in Neonatal Respiratory Distress Syndrome: A Narrative Review of the Last 10 Years
by Federico Costa, Annachiara Titolo, Mandy Ferrocino, Eleonora Biagi, Valentina Dell’Orto, Serafina Perrone and Susanna Esposito
Diagnostics 2024, 14(24), 2793; https://doi.org/10.3390/diagnostics14242793 (registering DOI) - 12 Dec 2024
Viewed by 444
Abstract
Neonatal respiratory distress syndrome (RDS) is a common and potentially life-threatening condition in preterm infants, primarily due to surfactant deficiency. Early and accurate diagnosis is critical to guide timely interventions such as surfactant administration and respiratory support. Traditionally, chest X-rays have been used [...] Read more.
Neonatal respiratory distress syndrome (RDS) is a common and potentially life-threatening condition in preterm infants, primarily due to surfactant deficiency. Early and accurate diagnosis is critical to guide timely interventions such as surfactant administration and respiratory support. Traditionally, chest X-rays have been used for diagnosis, but lung ultrasound (LUS) has gained prominence due to its non-invasive, radiation-free, and bedside applicability. Compared to chest X-rays and CT scans, LUS demonstrates superior sensitivity and specificity in diagnosing RDS, particularly in identifying surfactant need and predicting CPAP failure. Additionally, LUS offers real-time imaging without radiation exposure, an advantage over other modalities. However, its broader adoption is limited by challenges in standardizing training, ensuring diagnostic reproducibility, and validating scoring systems, especially in resource-limited settings. This narrative review aims to evaluate the role of LUS in the diagnosis and management of neonatal RDS over the past decade, focusing on its clinical utility, scoring systems, and emerging applications. We reviewed the literature from 2013 to 2023, focusing on studies evaluating LUS’ diagnostic accuracy, scoring systems, and its potential role in guiding surfactant therapy and predicting CPAP failure. Despite its benefits, addressing the variability in operator expertise and integrating artificial intelligence to enhance usability are crucial for ensuring LUS’ efficacy across diverse clinical environments. Future research should prioritize standardizing training and scoring protocols to facilitate wider implementation and optimize neonatal respiratory care outcomes. Full article
(This article belongs to the Special Issue Maternal–Fetal and Neonatal Diagnostics)
23 pages, 3021 KiB  
Article
Increased Levels of hsa-miR-199a-3p and hsa-miR-382-5p in Maternal and Neonatal Blood Plasma in the Case of Placenta Accreta Spectrum
by Angelika V. Timofeeva, Ivan S. Fedorov, Anastasia D. Nikonets, Alla M. Tarasova, Ekaterina N. Balashova, Dmitry N. Degtyarev and Gennady T. Sukhikh
Int. J. Mol. Sci. 2024, 25(24), 13309; https://doi.org/10.3390/ijms252413309 - 11 Dec 2024
Viewed by 446
Abstract
Despite the increasing number of placenta accreta spectrum (PAS) cases in recent years, its impact on neonatal outcomes and respiratory morbidity, as well as the underlying pathogenetic mechanism, has not yet been extensively studied. Moreover, no study has yet demonstrated the effectiveness of [...] Read more.
Despite the increasing number of placenta accreta spectrum (PAS) cases in recent years, its impact on neonatal outcomes and respiratory morbidity, as well as the underlying pathogenetic mechanism, has not yet been extensively studied. Moreover, no study has yet demonstrated the effectiveness of antenatal corticosteroid therapy (CT) for the prevention of respiratory distress syndrome (RDS) in newborns of mothers with PAS at the molecular level. In this regard, microRNA (miRNA) profiling by small RNA deep sequencing and quantitative real-time PCR was performed on 160 blood plasma samples from preterm infants (gestational age: 33–36 weeks) and their mothers who had been diagnosed with or without PAS depending on the timing of the antenatal RDS prophylaxis. A significant increase in hsa-miR-199a-3p and hsa-miR-382-5p levels was observed in the blood plasma of the newborns from mothers with PAS compared to the control group. A clear trend toward the normalization of hsa-miR-199a-3p and hsa-miR-382-5p levels in the neonatal blood plasma of the PAS groups was observed when CT was administered within 14 days before delivery, but not beyond 14 days. Direct correlations were found among the hsa-miR-382-5p level in neonatal blood plasma and the hsa-miR-199a-3p level in the same sample (r = 0.49; p < 0.001), the oxygen requirements in the NICU (r = 0.41; p = 0.001), the duration of the NICU stay (r = 0.31; p = 0.019), and the severity of the newborn’s condition based on the NEOMOD scale (r = 0.36; p = 0.005). Logistic regression models based on the maternal plasma levels of hsa-miR-199a-3p and hsa-miR-382-5p predicted the need for cardiotonic therapy, invasive mechanical ventilation, or high-frequency oscillatory ventilation in newborns during the early neonatal period, with a sensitivity of 95–100%. According to the literary data, these miRNAs regulate fetal organogenesis via IGF-1, the formation of proper lung tissue architecture, surfactant synthesis in alveolar cells, and vascular tone. Full article
(This article belongs to the Special Issue The Role of miRNA in Human Diseases)
Show Figures

Figure 1

Figure 1
<p>PLS-A analysis of deep sequencing data of miRNA in the peripheral blood plasma of day-old newborns from mothers with PAS and without PAS (control).</p>
Full article ">Figure 2
<p>The dependence of hsa-miR-382-5p and hsa-miR-199a-3p content in the blood plasma of newborns and their mothers on the severity of placenta accreta spectrum (PAS) and the timing of antenatal corticosteroid therapy (CT). Levels of miR-382-5p (−∆Ct, PCR data) in the blood plasma of newborns from mothers with placenta accreta or placenta increta or placenta percreta without CT or with CT 2–14 days before delivery in comparison with control group—without PAS and without CT (<b>A</b>). Levels of miR-382-5p (−∆Ct, PCR data) in the blood plasma of pregnant women with placenta accreta or placenta increta or placenta percreta without CT or with CT 2–14 days before delivery in comparison with control group—without PAS and without CT (<b>B</b>). Levels of miR-199a-3p (−∆Ct, PCR data) in the blood plasma of newborns from mothers with placenta accreta or placenta increta or placenta percreta without CT or with CT 2–14 days before delivery in comparison with control group—without PAS and without CT (<b>C</b>). Levels of miR-199a-3p (−∆Ct, PCR data) in the blood plasma of pregnant women with placenta accreta or placenta increta or placenta percreta without CT or with CT 2–14 days before delivery in comparison with control group—without PAS and without CT (<b>D</b>). “Wo” means “without”.</p>
Full article ">Figure 3
<p>Dynamics of changes in hsa-miR-199a-3p levels in the blood plasma of newborns relative to their mothers’ blood plasma, with and without PAS, depending on the antenatal corticosteroid therapy (CT). “Wo” means “without”.</p>
Full article ">Figure 4
<p>Levels of hsa-miR-199a-3p and hsa-miR-382-5p in the blood plasma of newborns with PAS, categorized by their severity score according to the Neomod scale.</p>
Full article ">Figure 5
<p>Levels of miR-181a-5p, miR-199a-3p and miR-382-5p in blood plasma of pregnant women with/without PAS and with/without antenatal corticosteroid therapy. “Wo” means “without”.</p>
Full article ">Figure 6
<p>Logistic regression models for predicting neonatal complications by plasma miR-199a-3p and/or miR-382-5p levels in pregnant women with PAS using miR-181a-5p as a reference endogenous RNA. (<b>A</b>) Respiratory complications probability models. (<b>B</b>) Cardiovascular complications probability models. Se—sensitivity, Sp—specificity.</p>
Full article ">Figure 7
<p>Enrichment analysis of gene targets of hsa-miR-382-5p and hsa-miR-199a-3p using FunRich software tool.</p>
Full article ">
21 pages, 5998 KiB  
Article
Assessment of Regional Brain Volume Measurements with Different Brain Extraction and Bias Field Correction Methods in Neonatal MRI
by Tânia F. Vaz, Nima Naseh, Lena Hellström-Westas, Nuno Canto Moreira, Nuno Matela and Hugo A. Ferreira
Appl. Sci. 2024, 14(24), 11575; https://doi.org/10.3390/app142411575 - 11 Dec 2024
Viewed by 443
Abstract
Proper selection and application of preprocessing steps are crucial for obtaining accurate segmentation in brain Magnetic Resonance Imaging (MRI). The aim of this study is to evaluate the impact brain extraction (BE) and bias field correction (BFC) methods have on regional brain volume [...] Read more.
Proper selection and application of preprocessing steps are crucial for obtaining accurate segmentation in brain Magnetic Resonance Imaging (MRI). The aim of this study is to evaluate the impact brain extraction (BE) and bias field correction (BFC) methods have on regional brain volume (RBV) measurements of preterm neonates’ T2w MRI at term-equivalent age (TEA). Five BE methods (Manual, BET2, SWS, HD-BET, SynthStrip) were applied together with two BFC methods (SPM-BFC and N4ITK), before segmenting the neonatal brain into eight tissue classes (cortical grey matter, white matter, cerebral spinal fluid, deep nuclear grey matter, hippocampus, amygdala, cerebellum, and brainstem) using an automated segmentation software (MANTiS). Quantitative assessments were conducted, including the coefficient of variation (CV), coefficient of joint variation (CJV), Dice coefficient (DC), and RBV. HD-BET, together with N4ITK, showed the highest performance (mean ± standard deviation) regarding CV of 0.047 ± 0.005 (white matter) and 0.070 ± 0.005 (grey matter), CJV of 0.662 ± 0.095, DC of 0.942 ± 0.063, and RBV without significant differences (except in the brainstem) from the manual segmentation. Therefore, such combination of methods is recommended for improved skull-stripping accuracy, intensity homogeneity, and reproducibility of RBV of T2w MRI at TEA. Full article
Show Figures

Figure 1

Figure 1
<p>Intensity inhomogeneity on TEA brain T2w MRI preterm neonate: (<b>a</b>) skull-stripped MRI without correction; (<b>b</b>) bias field map; bias-corrected MRI with (<b>c</b>) N4ITK and (<b>d</b>) SPM-BFC methods (images displayed with the Jet color map to ease the comparison between corrections).</p>
Full article ">Figure 2
<p>TEA brain T2w MRI (manually skull-stripped) of a preterm neonate in three different axial slices bias-corrected with SPM-BFC (<b>a</b>–<b>c</b>) and N4ITK (<b>d</b>–<b>f</b>), with overlaid brain tissues/structures segmented using MANTiS (color coded: CGM, red; WM, green; CSF, blue; DNGM, yellow; Hip, light blue; Amy, pink; CB, grey; BS, dark blue).</p>
Full article ">Figure 3
<p>Coefficient of joint variation (CJV) between white and grey matter intensities from MRI uncorrected and bias field-corrected with SPM-BFC and N4ITK, for each brain extraction method (Manual, BET2, SWS, HD-BET, and SynthStrip).</p>
Full article ">Figure 4
<p>Dice coefficient (DC) based on the regional brain tissue segmentation maps obtained from MRI uncorrected and bias field-corrected using SPM-BFC or N4ITK, for each brain extraction method (Manual, BET2, SWS, HD-BET, and SynthStrip).</p>
Full article ">Figure 5
<p>TEA brain T2w MRI (example bias-corrected with N4ITK) of a preterm neonate in three different axial slices (<b>a</b>) and corresponding skull-stripped images from each BE method ((<b>b</b>) Manual, (<b>c</b>) BET2, (<b>d</b>) SWS, (<b>e</b>) HD-BET, and (<b>f</b>) SynthStrip), overlaid with segmentation from MANTiS (color coded: CGM, red; WM, green; CSF, blue; DNGM, yellow; Hip, light blue; Amy, pink; CB, grey; BS, dark blue).</p>
Full article ">Figure A1
<p>Recovered bias field map overlapped with brain MRI in three different axial slices, with N4ITK bias field correction (BFC) applied before and after manual brain extraction (BE) (bias field map displayed in HSV color map to ease the comparison between corrections).</p>
Full article ">
14 pages, 918 KiB  
Article
Effect of Anesthetic Modality on Decision-to-Delivery Interval and Maternal–Neonatal Outcomes in Category 2 and 3 Cesarean Deliveries
by Polona Pečlin, Maja Pavlica, Mirjam Druškovič, Gorazd Kavšek, Ivan Verdenik and Tatjana Stopar Pintarič
J. Clin. Med. 2024, 13(24), 7528; https://doi.org/10.3390/jcm13247528 - 11 Dec 2024
Viewed by 316
Abstract
Background/Objectives: The optimal anesthetic technique for category 2 and 3 cesarean deliveries remains debated, with concerns about impacts on decision-to-delivery interval (DDI) and perinatal outcomes. This study examined the influence of epidural, spinal, and general anesthesia on DDI, surgical and postoperative complications, and [...] Read more.
Background/Objectives: The optimal anesthetic technique for category 2 and 3 cesarean deliveries remains debated, with concerns about impacts on decision-to-delivery interval (DDI) and perinatal outcomes. This study examined the influence of epidural, spinal, and general anesthesia on DDI, surgical and postoperative complications, and neonatal outcomes. Methods: This prospective cohort study at a tertiary perinatology center enrolled parturient women undergoing category 2 and 3 cesarean deliveries. Three DDI phases were assessed for each anesthetic modality: transfer time (decision for cesarean section to admission in the operation room), anesthetic time (admission to incision), and delivery time (incision to delivery of the neonate). The surgical procedure time (incision to closure), neonatal (5 min Apgar score, umbilical artery pH/base excess, neonatal intensive care unit (NICU) admission) and maternal (blood loss, surgical and postoperative complications) outcomes were also analyzed for each group. Results: There were 215 women (122 category 2 and 93 category 3) included. The use of epidural and general anesthesia was associated with significantly shortened DDI compared to spinal anesthesia (p < 0.001). This difference was due prolonged transfer (p < 0.05) and anesthetic times (p < 0.001), respectively. No cases of umbilical artery pH below 7 were observed in any group. No significant differences were observed in the incidence of umbilical artery pH between 7 and 7.10 or in base excess below −12 nmol/L (p = 0.416 and p = 0.865, respectively). NICU admission was higher with both general and spinal anesthesia (p = 0.021), but mainly due to a higher proportion of preterm births, both before the 32nd week (p = 0.033) and between the 32nd and 37th week of pregnancy (p < 0.001). General anesthesia was associated with higher maternal blood loss (p = 0.026) and a higher rate of postoperative complications (p = 0.006). Conclusions: In category 2 and 3 cesarean deliveries, general and epidural anesthesia were associated with shorter DDI compared to spinal anesthesia with no differences in neonatal outcomes. General anesthesia was associated with a higher risk of maternal complications compared to neuraxial anesthetic techniques. Full article
(This article belongs to the Section Anesthesiology)
Show Figures

Figure 1

Figure 1
<p>Flowchart of the patient enrollment process. GA = general anesthesia, EA = epidural anesthesia.</p>
Full article ">Figure 2
<p>Cumulative Kaplan–Meier curves for anesthesia time (admission to the operation room to first skin incision). The graph depicts the cumulative percentage of category 2 and 3 cesarean deliveries in relation to the time elapsed from entering the operating room to the first incision, stratified by the type of anesthesia used. GA = general anesthesia, EA = epidural anesthesia.</p>
Full article ">Figure 3
<p>Cumulative Kaplan–Meier curves for DDI (decision-to-delivery interval). The graph depicts the cumulative percentage of categories 2 and 3 cesarean deliveries in relation to the time elapsed from decision to perform cesarean delivery to delivery of the neonate, stratified by the type of anesthesia used. GA = general anesthesia, EA = epidural anesthesia.</p>
Full article ">
9 pages, 702 KiB  
Article
Effect of Skin-to-Skin Care on the Day of Birth on Skin Colonization in Preterm Infants: A Pre- and Post-Implementation Study
by Poorva Deshpande, Nosheen Akhtar, Maura Mansur, Allison McGeer and Vibhuti Shah
Children 2024, 11(12), 1506; https://doi.org/10.3390/children11121506 - 10 Dec 2024
Viewed by 431
Abstract
Background/Objectives: Maternal skin-to-skin contact (MSSC) in neonates has been shown to reduce nosocomial infections. In preterm infants, exposure to maternal skin commensals within the first 24 h may prevent colonization by hospital-acquired pathogens. However, the impact of early MSSC on skin colonization in [...] Read more.
Background/Objectives: Maternal skin-to-skin contact (MSSC) in neonates has been shown to reduce nosocomial infections. In preterm infants, exposure to maternal skin commensals within the first 24 h may prevent colonization by hospital-acquired pathogens. However, the impact of early MSSC on skin colonization in preterm infants is unknown. Our aim was to compare skin colonization patterns on days 2, 3, and 7 of life in preterm infants (280/7 to 316/7 weeks gestational age) who received MSSC within the first 24 h from birth with those who did not. The primary outcome was the rate of skin colonization with bacterial pathogens. The secondary outcome was the rate of Staphylococcus aureus colonization. Methods: This prospective pre- and post-implementation study was conducted at Mount Sinai Hospital, Toronto. Skin swabs were obtained at 24–36 h, 48–72 h, and day 7 of life. Infant mouth and rectal swabs were collected on day 7. Maternal nasal–rectal swabs were obtained at any time from recruitment to day 7. Results: Twenty-seven infants were included in the pre-implementation group and seventeen were included in the post-implementation group, respectively. Post-implementation infants received an increased duration of SSC during the first week. No differences in colonization with pathogens vs. commensals or Staphylococcus aureus colonization were observed between groups at any time point. Skin was fully colonized in both groups by day 7. Conclusions: No differences in skin colonization patterns were identified in the first week of life for preterm infants receiving early MSSC. Larger studies with longitudinal data are needed to further evaluate the impact of MSSC on skin colonization. Full article
(This article belongs to the Section Pediatric Neonatology)
Show Figures

Figure 1

Figure 1
<p>Number of infants who completed skin swabs on days 2, 3 and 7.</p>
Full article ">Figure 2
<p>Distribution of organisms isolated on days 2, 3, and 7 in the pre-implementation (<b>A</b>) and post-implementation (<b>B</b>) groups. CONS: coagulase-negative <span class="html-italic">Staphylococci</span>; E. Coli: <span class="html-italic">Escherichia coli</span>; E. Fecalis: <span class="html-italic">Enterococcus Fecalis</span>; K. pneumoniae: <span class="html-italic">Klebsiella pneumoniae</span>; S. Aureus: <span class="html-italic">Staphylococcus aureus;</span> MRSA: methicillin-resistant <span class="html-italic">Staphylococcus aureus</span>.</p>
Full article ">
15 pages, 2614 KiB  
Article
The Unsung Heroes: The Profile of the Donor at a Southern Italian Milk Bank and Driving Factors in Human Milk Donation
by Pasqua Anna Quitadamo, Laura Comegna, Federica Zambianco, Giuseppina Palumbo, Massimiliano Copetti, Maria Assunta Gentile, Antonio Mondelli, Isadora Beghetti and Luigi Corvaglia
Children 2024, 11(12), 1502; https://doi.org/10.3390/children11121502 - 10 Dec 2024
Viewed by 454
Abstract
Background/Objectives: One of the most effective strategies to mitigate morbidity associated with preterm birth is the use of human milk. The first choice is the mother’s milk; if that is not available, human milk donated to milk banks is the second choice. The [...] Read more.
Background/Objectives: One of the most effective strategies to mitigate morbidity associated with preterm birth is the use of human milk. The first choice is the mother’s milk; if that is not available, human milk donated to milk banks is the second choice. The recruitment of milk donors is essential for enhancing the effectiveness and efficiency of donation. This study aims to profile the donors of a southern Italian milk bank, examine how maternal and neonatal factors impacted the volume and duration of donation and analyze the trend over the last ten years. Materials and Methods: Data were collected from the milk bank database and hospitalization medical records, encompassing 593 donors and 13 years of activity of the Human Milk Bank from 2010 to 2022. Several variables were assessed: maternal characteristics—maternal age, employment status and the type of profession; pre and perinatal characteristics—type of delivery, parity, previous breastfeeding experience, birth weight and gestational age; milk donation characteristics—volume of milk donated and duration of donation. The trend of the characteristics was studied over time. Statistical correlations were conducted to assess the relationships between variables and the volume and duration of the milk donation. Results: In our cohort of donors, the most prevalent category consists of women over 30 years of age who are multiparous, have prior breastfeeding experience, are workers and have given birth to full-term babies. Maternal age and gestational age significantly influence both the volume and duration of milk donation. The type of delivery and occupation impact the volume of donated milk. There has been a decline in the number of donors over time. However, the trends in both the quantity and duration of milk donations have remained stable over the past decade, with the exception of the year immediately following the COVID-19 pandemic. Conclusions: We have outlined the prevailing average profile of the milk donor to a milk bank in Southern Italy. Factors impacting the volume and duration of donation, such as maternal age, occupation, type of delivery and gestational age, were identified. The volume and duration of donations have remained largely stable, with the exception of 2021, when the pandemic significantly reduced milk donations to the milk bank. Full article
(This article belongs to the Special Issue Promoting Breastfeeding and Human Milk in Infants)
Show Figures

Figure 1

Figure 1
<p>Distribution by maternal age group. Representation of age variable categorized by age groups. The categories represent the numerical sample of donors for each individual age group across the years.</p>
Full article ">Figure 2
<p>Annual Trend of Donor Age. Trend of the age variable categorized into age groups. The data for age groups are expressed as percentages corresponding to individual years.</p>
Full article ">Figure 3
<p>Parity. Percentage of women in the categories of primiparous and multiparous.</p>
Full article ">Figure 4
<p>Previous breastfeeding. Data expressed as the percentage of women with previous breastfeeding experience compared to those without.</p>
Full article ">Figure 5
<p>Occupation. A total of 54.3% of the donors were working, compared to 46.7% who were housewives.</p>
Full article ">Figure 6
<p>Previous breastfeeding and employment. Trends over the years of the variables expressed as the percentage of women who did not previously breastfeed and who are not working in the annual population of donors.</p>
Full article ">Figure 7
<p>Percentage distribution of natural births and cesarean sections over the specified period.</p>
Full article ">Figure 8
<p>Trends over the years in donation characteristics: number of donors, average donation duration (in days) and average volume donated (in mL).</p>
Full article ">Figure 9
<p>Annual trend of donor percentage among women who gave birth in the San Giovanni Rotondo.</p>
Full article ">
15 pages, 524 KiB  
Study Protocol
Describing Biological Vulnerability in Small, Vulnerable Newborns in Urban Burkina Faso (DenBalo): Gut Microbiota, Immune System, and Breastmilk Assembly
by Lionel Olivier Ouédraogo, Lishi Deng, Cheick Ahmed Ouattara, Anderson Compaoré, Moctar Ouédraogo, Alemayehu Argaw, Carl Lachat, Eric R. Houpt, Queen Saidi, Filomeen Haerynck, Justin Sonnenburg, Meghan B. Azad, Simon J. Tavernier, Yuri Bastos-Moreira, Laeticia Celine Toe and Trenton Dailey-Chwalibóg
Nutrients 2024, 16(23), 4242; https://doi.org/10.3390/nu16234242 - 9 Dec 2024
Viewed by 594
Abstract
Background: Small vulnerable newborns (SVNs), including those born preterm, small for gestational age, or with low birth weight, are at higher risk of neonatal mortality and long-term health complications. Early exposure to maternal vaginal microbiota and breastfeeding plays a critical role in [...] Read more.
Background: Small vulnerable newborns (SVNs), including those born preterm, small for gestational age, or with low birth weight, are at higher risk of neonatal mortality and long-term health complications. Early exposure to maternal vaginal microbiota and breastfeeding plays a critical role in the development of the neonatal microbiota and immune system, especially in low-resource settings like Burkina Faso, where neonatal mortality rates remain high. Objectives: The DenBalo study aims to investigate the role of maternal and neonatal factors, such as vaginal and gut microbiota, immune development, and early nutrition, in shaping health outcomes in SVNs and healthy infants. Methods: This prospective cohort observational study will recruit 141 mother-infant pairs (70 SVNs and 71 healthy controls) from four health centers in Bobo-Dioulasso, Burkina Faso. The mother-infant pairs will be followed for six months with anthropometric measurements and biospecimen collections, including blood, breast milk, saliva, stool, vaginal swabs, and placental biopsies. Multi-omics approaches, encompassing metagenomics, metabolomics, proteomics, and immune profiling, will be used to assess vaginal and gut microbiota composition and functionality, immune cell maturation, and cytokine levels at critical developmental stages. Conclusions: This study will generate comprehensive data on how microbiota, metabolomic, and proteomic profiles, along with immune system development, differ between SVNs and healthy infants. These findings will guide targeted interventions to improve neonatal health outcomes and reduce mortality, particularly in vulnerable populations. Full article
(This article belongs to the Section Pediatric Nutrition)
Show Figures

Figure 1

Figure 1
<p>Flow chart of the DenBalo study schedule.</p>
Full article ">
12 pages, 855 KiB  
Review
Probiotics in the Prophylaxis of Premature Rupture of Membranes and Cervical Incompetence
by Constantin-Cristian Vaduva, Ana-Maria Petrescu, Laurentiu Mihai Dira, Dan Ruican and Razvan Cosmin Pana
Nutrients 2024, 16(23), 4230; https://doi.org/10.3390/nu16234230 - 6 Dec 2024
Viewed by 604
Abstract
Premature rupture of membranes (PROM) and cervical incompetence (CI) are major contributors to preterm birth, a leading cause of neonatal morbidity and mortality. Background/Objectives: Disorders of the vaginal microbiota, such as bacterial vaginosis, have been associated with an increased risk of PROM, CI, [...] Read more.
Premature rupture of membranes (PROM) and cervical incompetence (CI) are major contributors to preterm birth, a leading cause of neonatal morbidity and mortality. Background/Objectives: Disorders of the vaginal microbiota, such as bacterial vaginosis, have been associated with an increased risk of PROM, CI, and subsequent preterm birth. Probiotics, particularly Lactobacillus strains, have been proposed as a preventive strategy to restore and maintain a healthy vaginal microbiome. This review aims to summarize the latest evidence on the role of probiotics in the prevention of PROM and CI. Methods: A comprehensive review was conducted to evaluate the effectiveness of probiotic interventions in the prevention of PROM and CI, yielding 1809 records from 2005 to 2024. Seven relevant studies were selected by searching medical databases and focusing on studies that investigated the restoration of healthy vaginal flora, the reduction of pathogenic bacteria colonization, and the modulation of immune responses by probiotics. Results: The studies analyzed suggest that probiotics may help restore healthy vaginal flora, reduce pathogenic bacterial colonization, and modulate immune responses, thereby reducing the risk of membrane rupture and cervical insufficiency. Evidence from randomized controlled trials and observational studies shows that the use of probiotics is associated with a lower incidence of PROM and preterm birth, especially in high-risk groups. Conclusions: Probiotics emerge as a potential non-invasive and cost-effective strategy to improve pregnancy outcomes in women at risk of preterm birth due to PROM. According to our research, probiotic prophylaxis of cervical insufficiency has not yet been sufficiently investigated. Despite the promising findings, further research is needed to determine standardized probiotic formulations, optimal timing, and routes of administration. Personalized probiotic therapies may represent the future of preterm birth prevention as they offer targeted interventions based on individual microbiome composition. Full article
Show Figures

Scheme 1

Scheme 1
<p>PRISMA diagram of the eligible studies included in the review.</p>
Full article ">Scheme 2
<p>Summary of results. Probiotic prophylaxis may reduce the risk of premature rupture of membranes and improve the mean gestational age at delivery. The effects on cervical incompetence have not yet been sufficiently researched.</p>
Full article ">
11 pages, 881 KiB  
Article
Serum Folate Concentrations in Exclusively Breastfed Preterm Infants Who Received No Supplementary Oral Folic Acid After Discharge: A Prospective Cohort Study
by Isabel Iglesias-Platas, Agata Sobczyńska-Malefora, Vennila Ponnusamy, Ajit Mahaveer, Kieran Voong, Amy Nichols, Karen Dockery, Nicky Holland, Shaveta Mulla, Martin J. Shearer, David Card, Lindsay J. Hall, Dominic J. Harrington and Paul Clarke
Nutrients 2024, 16(23), 4220; https://doi.org/10.3390/nu16234220 - 6 Dec 2024
Viewed by 692
Abstract
Background/Objectives: Adequate folate intake is required in preterm infants for rapid growth and development, but there is little evidence to back recommendations. We aimed to assess folate status in preterm infants at discharge and in early infancy, according to exposure to folate sources, [...] Read more.
Background/Objectives: Adequate folate intake is required in preterm infants for rapid growth and development, but there is little evidence to back recommendations. We aimed to assess folate status in preterm infants at discharge and in early infancy, according to exposure to folate sources, particularly in those exclusively/predominantly breastfed. Methods: A prospective, multicenter, observational cohort study was conducted in the UK, involving 45 preterm infants <33 weeks’ gestational age (GA) exclusively/predominantly fed human milk when approaching NICU (Neonatal Intensive Care Unit) discharge. Serum folate levels were measured near NICU discharge (T1) and at 2–3 months corrected age (T2). Folate status was categorized per WHO (World Health Organization) guidelines: deficiency (<6.8 nmol/L), possible deficiency (6.8–13.4 nmol/L), normal (13.5–45.3 nmol/L), and elevated (>45.3 nmol/L). Nutritional information on feed and supplements was collected from hospital notes and maternal interviews. Results: Thirty-two infants (71%) received parenteral nutrition. Twelve infants (32%) remained exclusively breastfed at T2. No infant from the whole cohort had a serum folate concentration <13.5 nmol/L at either time point. A proportion of infants had serum folate concentrations >45.3 nmol/L: 14/45 (31%) at T1, 19/37 (42%) at T2, and 7/37 (16%) at both time points. Elevated concentrations were seen particularly in infants who received folic acid supplements or nutrition containing folic acid, such as parenteral nutrition and breastmilk fortifiers. Conclusions: Folate deficiency was not observed in this cohort; folate concentrations were high and in line with those observed in healthy term infants. Further research is needed to assess the high folate concentrations in premature babies and whether they may have any adverse clinical impact. Full article
Show Figures

Figure 1

Figure 1
<p>Folate status in preterm infants. (<b>1</b>) Serum folate concentrations for each participant at T1 (pre-discharge) and at T2 (follow-up). The dotted lines link the folate concentrations for each patient at each time point. Concentrations were significantly higher at T2 (n = 37 pairs, T1 mean 38.9, SD 9.1 nmol/L; T2 mean 43.0, SD 4.2 nmol/L, <span class="html-italic">p</span> = 0.01, repeated measures <span class="html-italic">t</span>-test). (<b>2</b>) Percentage and number of participants with folate concentrations that were normal, elevated at one time point, or elevated at both time points are represented by the white, light gray, and dark gray areas on the bars, respectively. (<b>3</b>) Serum folate concentrations according to feeding type at T1 and T2. Each individual symbol (x, ✴, +, ★) represents one data point for each feeding category. Lines and error bars represent medians and interquartile ranges, respectively. Mother’s Own Milk (MOM).</p>
Full article ">
Back to TopTop